Keywords: Amino Acid Derivative, Fluorine 18, Iodine 123, Methionine C 11, Radiopharmaceutical Agent, Tyrosine, Blood Brain Barrier, Brain Tumor, Human, Isotope Labeling, Medical Error, Medical Information, Medical Practice, Medical Society, Neuroimaging, Positron Emission Tomography, Practice Guideline, Quality Control, Quantitative Analysis, Radiation Dose, Review, Single Photon Emission Computer Tomography, Treatment Planning, Tumor Biopsy, Tumor Diagnosis, Brain Neoplasms, Nuclear Medicine, Physician, S Practice Patterns, Radioisotopes, Emission-Computed,
Affiliations: *** IBB - CNR ***
Nuclear Medicine Division, Mont-Godinne Medical Center, University Catholique de Louvain, Louvain, Belgium
Department of Neurology, Medical University of Vienna, Vienna, Austria
Department of Nuclear Medicine, Johannes Gutenberg University, Mainz, Germany
Department of Clinical Neuroscience, Section of Psychiatry, Karolinska Institutet, Stockholm, Sweden
Division of Nuclear Medicine, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium
Biostructure and Bioimaging Institute, National Research Council, Napoli, Italy
Department of Health Sciences, University of Molise, Campobasso, Italy
Neuroradiologia, Dipartimento di Scienze Radiologiche, Istituto Scientifico Casa Sollievo della Sofferenza, San Giovanni Rotondo (Fg), Italy
Department of Radiology, University of Novara, Novara, Italy
MR Laboratory, Stella Maris Scientific Institute, Calabrone, Pisa, Italy
University of Bari, Bari, Italy
Radiologia, Università di Novara, Novara, Italy
Neuroradiologia, Università Politecnica delle Marche, Ancona, Italy
Dipartimento di Radiologia, AUSL BA/1, Andria (Ba), Italy
References: Jager, P.L., Vaalburg, W., Pruim, J., De Vries, E.G., Langen, K.J., Piers, D.A., Radiolabeled amino acids: Basic aspects and clinical applications in oncology (2001) J Nucl Med, 42, pp. 432-44
Langen, K.J., Pauleit, D., Coenen, H.H., 3-[123I]Iodo-α-methyl-Ltyrosine: Uptake mechanisms and clinical applications (2002) Nucl Med Biol, 29, p. 631
Laverman, P., Boerman, O.C., Corstens, F.H., Oyen, W.J., Fluorinated amino acids for tumour imaging with positron emission tomography (2002) Eur J Nucl Med Mol Imaging, 29, pp. 681-690
Kracht, L.W., Miletic, H., Busch, S., Jacobs, A.H., Voges, J., Hoevels, M., Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: Local comparison with stereotactic histopathology (2004) Clin Cancer Res, 10, pp. 7163-7170
Pauleit, D., Floeth, F., Herzog, H., Hamacher, K., Tellmann, L., Müller, H.W., Whole-body distribution and dosimetry of O-(2-[18F]fluoroethy) -L-tyrosine (2003) Eur J Nucl Med Mol Imaging, 30, pp. 519-524
Pirotte, B., Goldman, S., Massager, N., David, P., Wikler, D., Vandesteene, A., Comparison of18F-FDG and123C-methionine for PET-guided stereotactic brain biopsy of gliomas (2004) J Nucl Med, 45, pp. 1293-1298
Riemann, B., Papke, K., Hoess, N., Kuwert, T., Weckesser, M., Matheja, P., Noninvasive grading of untreated gliomas: A comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT (2002) Radiology, 225, pp. 567-574
Kracht, L.W., Friese, M., Herholz, K., Schroeder, R., Bauer, B., Jacobs, A., Methyl-[11C]- L-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma (2003) Eur J Nucl Med Mol Imaging, 30, pp. 868-873
De Witte, O., Goldberg, I., Wikler, D., Rorive, S., Damhaut, P., Monclus, M., Positron emission tomography with injection of methionine as a prognostic factor in glioma (2001) J Neurosurg, 95, pp. 746-750
Levivier, M., Massager, N., Wikler, D., Lorenzoni, J., Ruiz, S., Devriendt, D., Use of stereotactic PET images in dosimetry planning of radiosurgery for brain tumors: Clinical experience and proposed classification (2004) J Nucl Med, 45, pp. 1146-1154
Lahoutte, T., Caveliers, V., Franken, P.R., Bossuyt, A., Mertens, J., Everaert, H., Increased tumor uptake of 3-123I-iodo-L-alpha-methyltyrosine after preloading with amino acids: An in vivo animal imaging study (2002) J Nucl Med, 43, pp. 1201-1206
Deloar, H.M., Fujiwara, T., Nakamura, T., Itoh, M., Imai, D., Miyake, M., Estimation of internal absorbed dose of L-[methyl-11C] methionine using whole-body positron emission tomography (1998) Eur J Nucl Med, 25, pp. 629-633
Schmidt, D., Langen, K.J., Herzog, H., Wirths, J., Holschbach, M., Kiwit, J.C., Whole-body kinetics and dosimetry of L-3-123I-iodo-alpha- methyltyrosine (1997) Eur J Nucl Med, 24, pp. 1162-1166
Kuwert, T., Morgenroth, C., Woesler, B., Matheja, P., Palkovic, S., Vollet, B., Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions (1996) Eur J Nucl Med, 23, pp. 1345-1353
Kuwert, T., Woesler, B., Morgenroth, C., Lerch, H., Schafers, M., Palkovic, S., Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine (1998) J Nucl Med, 39, pp. 23-27
Weber, W.A., Dick, S., Reidl, G., Dzewas, B., Busch, R., Feldmann, H.J., Correlation between postoperative 3-[123I]iodo-L-alpha- methyltyrosine uptake and survival in patients with gliomas (2001) J Nucl Med, 42, pp. 1144-1150
Van Laere, K., Ceyssens, S., Van Calenbergh, F., De Groot, T., Menten, J., Flamen, P., Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: Sensitivity, inter-observer variability and prognostic value (2005) Eur J Nucl Med Mol Imaging, 32, pp. 39-51
Cook, G.J., Maisey, M.N., Fogelman, I., Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine (1999) Eur J Nucl Med, 26, pp. 1363-1378
Behin, A., Hoang-Xuan, K., Carpentier, A.F., Delattre, J.-Y., Primary brain tumours in adults (2003) Lancet, 361, pp. 323-33
Grant, R., Overview: Brain tumour diagnosis and management. Royal College of Physicians guidelines (2004) J Neurol Neurosurg Psychiatry, 75 (SUPPL. 2), pp. 18-23
Howe, F.A., Opstad, K.S., 1HMR spectroscopy of brain tumor and masses (2003) NMR Biomed, 16, pp. 123-131
McKnight, T.R., Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism (2004) Semin Oncol, 31, pp. 605-617
Li, X., Lu, Y., Pirzkall, A., McKnight, T., Nelson, S.J., Analysis of the spatial characteristics ofmetabolic abnormalities in newly diagnosed glioma patients (2002) J Magn Reson Imaging, 16, pp. 229-237
Burtscher, I.M., Skagerberg, G., Geijer, B., Proton MR spectroscopy and preoperative diagnostic accuracy: An evaluation of intracranialmass lesions characterized by stereotactic biopsy findings (2000) Am J Neuroradiol, 21, pp. 84-93
Dowling, C., Bollen, A.W., Noworolski, S.M., Preoperative proton MR spectroscopic imaging of brain tumors: Correlation with histopathologic analysis of resection specimens (2001) Am J Neuroradiol, 22, pp. 604-612
Croteau, D., Scarpace, L., Hearshen, D., Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: Semiquantitative and qualitative histopathological analyses of patients with untreated glioma (2001) Neurosurgery, 49, pp. 823-829
Rabinov, J.D., Lee, P.L., Barker, F.G., In vivo 3-TMR spectroscopy in the distinction of recurrent glioma versus radiation effects: Initial experience (2002) Radiology, 225, pp. 871-879
Tedeschi, G., Lundbom, N., Raman, R., Increased choline signal coinciding with malignant degeneration of cerebral gliomas: A serial protonmagnetic resonance spectroscopy imaging study (1997) J Neurosurg, 87, pp. 516-524
Sener, R.N., Diffusion MRI: Apparent diffusion coefficient (ADC) values in the normal brain and a classification of brain disorders based on ADC values (2001) ComputMed Imaging Graph, 25, pp. 299-326
Kono, K., Inoue, Y., Nakayama, K., The role of diffusion-weighted imaging in patients with brain tumors (2001) Am J Neuroradiol, 22, pp. 1081-1088
Asao, C., Korogi, Y., Kitajima, M., Diffusionweighted imaging of radiation-induced brain injury for differentiation from tumor recurrence (2005) Am J Neuroradiol, 26, pp. 1455-1460
Muti, M., Aprile, I., Principi, M., Study on the variations of the apparent diffusion coefficient in areas of solid tumor in high grade gliomas (2002) Magn Reson Imaging, 20, pp. 635-641
Yamasaki, F., Kurisu, K., Satoh, K., Apparentdiffusion coefficient of human brain tumors at MR imaging (2005) Radiology, 235, pp. 985-991
Lam, W.W.M., Poon, W.S., Metreweli, C., Diffusion MR imaging in glioma: Does it have any role in the pre-operation determination of grading of glioma? (2002) Clin Radiol, 57, pp. 219-225
Tien, R.D., Felsberg, G.J., Friedman, H., MR imaging of high-grade cerebral gliomas: Value of diffusionweighted echoplanar pulse sequences (1994) Am J Roentgenol, 162, pp. 671-677
Maia, A.C.M., Malheiros, S.M.F., Da Rocha, A.J., MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas (2005) Am J Neuroradiol, 26, pp. 777-783
Law, M., Yang, S., Babb, J.S., Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusionMR imaging with glioma grade (2004) Am J Neuroradiol, 25, pp. 746-755
Lev, M.H., Ozsunar, Y., Henson, J.W., Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhancedMR: Confounding effect of elevated rCBV of oligodendrogliomas (2004) Am J Neuroradiol, 25, pp. 214-221
Cha, S., Tihan, T., Crawford, F., Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging (2005) Am J Neuroradiol, 26, pp. 266-273
Frayne, R., Goodyear, B.G., Dickhoff, P., Magnetic resonance imaging at 3.0 Tesla: Challenges and advantages in clinical neurological imaging (2003) Invest Radiol, 38, pp. 385-402
Di Costanzo, A., Trojsi, F., Tosetti, M., High-field proton MRS of human brain (2003) Eur J Radiol, 48, pp. 146-153
Counsell, C.E., Grant, R., Incidence studies of primary and secondary intracranial tumours: A systematic review of their methodology and results (1998) J Neurooncol, 37, pp. 241-250
Prados, M., Neoplasms of the central nervous system (2000) Cancer Medicine, pp. 1055-1082. , Bast R, Kufe D, Pollock R,WeichselbaumR, Holland J, Frei E (eds), 5th edn. BC Decker, Hamilton, Ontario
Yuh, W.T., Nguyen, H.D., Tali, E.T., Delineation of gliomas with various doses of MR contrast material (1994) AmJ Neuroradiol, 15, pp. 983-989
Kleihues, P., Cavenee, W.K., Pathology and Genetics of Tumours of the Nervous System, , IARC Press, Lyon, France
Fallentin, E., Skriver, E., Herning, M., Gliomatosis cerebri: An appropriate diagnosis? Case reports (1997) Acta Radiol, 38, pp. 381-390
Barnard, R.O., Geddes, J.F., The incidence of multifocal cerebral gliomas: A histologic study of large hemisphere sections (1987) Cancer, 60, pp. 1519-1531
Artigas, J., Cervos-Navarro, J., Iglesias, J.R., Gliomatosis cerebri: Clinical and histological findings (1985) Clin Neuropathol, 4, pp. 135-148
Castillo, M., Smith, J.K., Kwock, L., Wilber, K., Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas (2001) Am J Neuroradiol, 22, pp. 60-64
Law, M., Cha, S., Knopp, E.A., High-grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR imaging (2002) Radiology, 222, pp. 715-721
Tzika, A.A., Astrakas, L.G., Zarifi, M.K., MultiparametricMR assessment of pediatric brain tumors (2003) Neuroradiology, 45, pp. 1-10
Chiang, I.C., Kuo, Y.-T., Lu, C.-Y., Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings (2004) Neuroradiology, 46, pp. 619-627
Strugar, J.G., Criscuolo, G.R., Rothbart, D., Harrington, W.N., Vascular endothelial growth/permeability factor expression in human glioma specimens: Correlation with vasogenic brain edema and tumor-associated cysts (1995) J Neurosurg, 83, pp. 682-689
Cha, S., Johnson, G., Wadghiri, Y.Z., Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: Correlation with histopathology (2003) Magn Reson Med, 49, pp. 848-855
Strugar, J., Rothbart, D., Harrington, W., Criscuolo, G.R., Vascular permeability factor in brain metastases: Correlation with vasogenic brain edema and tumor angiogenesis (1994) J Neurosurg, 81, pp. 560-566
Eis, M., Els, T., Hoehn-Berlage, M., High resolution quantitative relaxation and diffusion MRI of three different experimental brain tumors in rat (1995) Magn Reson Med, 34, pp. 835-844
Black, P.M., Meningiomas (1993) Neurosurgery, 32, pp. 643-657
Mahmood, A., Caccamo, D.V., Tomecek, F.J., Atypical and malignant meningiomas: A clinicopathological review (1993) Neurosurgery, 33, pp. 955-963
Maier, H., Ofner, D., Hittmair, A., Classic, atypical, and anaplastic meningioma: Three histopathological subtypes of clinical relevance (1992) J Neurosurg, 77, pp. 616-623
Nakano, T., Asano, K., Miura, H., Meningiomas with brain edema. Radiological characteristics on MRI and review of the literature (2002) Clin Imaging, 26, pp. 243-249
Yang, S., Law, M., Zagzag, D., Dynamic contrastenhanced perfusion MR imaging measurements of endothelial permeability: Differentiation between atypical and typical meningiomas (2003) Am J Neuroradiol, 24, pp. 1554-1559
Cho, Y.-D., Choi, G.-H., Lee, S.-P., Kim, J.-K., 1H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors (2003) Magn Reson Imaging, 21, pp. 663-672
Provenzale, J.M., McGraw, P., Mhatre, P., Peritumoral brain regions in gliomas and meningiomas: Investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging (2004) Radiology, 232, pp. 451-460
Cha, S., Perfusion MR imaging of brain tumors (2004) Top Magn Reson Imaging, 15, pp. 279-289
Jellinger, K.A., Paulus, W., Primary central nervous system lymphomas - An update (1992) J Cancer Res Clin Oncol, 119, pp. 7-27
Lai, R., Rosenblum, M.K., Deangelis, L.M., Primary CNS lymphoma. A whole-brain disease? (2002) Neurology, 59, pp. 1557-1562
Larocca, L.M., Capello, D., Rinelli, A., The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation fromgerminal center-related B cells (1998) Blood, 92, pp. 1011-1019
Buhring, U., Herrlinger, U., Krings, T., MRI features of primary central nervous system lymphomas at presentation (2001) Neurology, 57, pp. 393-396
Küker, W., Nägele, T., Korfel, A., Primary central nervous systemlymphomas (PCNSL):MRI features at presentation in 100 patients (2005) J Neurooncol, 72, pp. 169-177
Hartmann, M., Heiland, S., Harting, I., Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging (2003) Neurosci Lett, 338, pp. 119-122
Onda, K., Wakabayashi, K., Tanaka, R., Takahashi, H., Intracranial malignant lymphomas: Clinicopathological study of 26 autopsy cases (1999) Brain Tumor Pathol, 16, pp. 29-35
Deangelis, L.M., Brain tumors (2001) N Engl JMed, 344, pp. 114-123
Jeyapalan, S., Batchelor, T., Diagnostic evaluation of neurologic metastases (2000) Cancer Invest, 18, pp. 381-394
Hwang, T., Close, T., Grego, J., Predilection of brain metastasis in grey and white matter junction and vascular border zones (1996) Cancer, 77, pp. 1551-1555
Krabbe, K., Gideon, P., Wagn, P., MR diffusion imaging of human intracranial tumours (1997) Neuroradiology, 39, pp. 483-489
Kremer, S., Grand, S., Berger, F., Dynamic contrast-enhanced MRI: Differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases (2003) Neuroradiology, 45, pp. 44-49
Jager, P. L., Vaalburg, W., Pruim, J., De Vries, E. G., Langen, K. J., Piers, D. A., Radiolabeled amino acids: Basic aspects and clinical applications in oncology (2001) J Nucl Med, 42, pp. 432-44
Langen, K. J., Pauleit, D., Coenen, H. H., 3- [123I] Iodo- -methyl-Ltyrosine: Uptake mechanisms and clinical applications (2002) Nucl Med Biol, 29, p. 631
Kracht, L. W., Miletic, H., Busch, S., Jacobs, A. H., Voges, J., Hoevels, M., Delineation of brain tumor extent with [11C] L-methionine positron emission tomography: Local comparison with stereotactic histopathology (2004) Clin Cancer Res, 10, pp. 7163-7170
Kracht, L. W., Friese, M., Herholz, K., Schroeder, R., Bauer, B., Jacobs, A., Methyl- [11C] - L-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma (2003) Eur J Nucl Med Mol Imaging, 30, pp. 868-873
Deloar, H. M., Fujiwara, T., Nakamura, T., Itoh, M., Imai, D., Miyake, M., Estimation of internal absorbed dose of L- [methyl-11C] methionine using whole-body positron emission tomography (1998) Eur J Nucl Med, 25, pp. 629-633
Weber, W. A., Dick, S., Reidl, G., Dzewas, B., Busch, R., Feldmann, H. J., Correlation between postoperative 3- [123I] iodo-L-alpha- methyltyrosine uptake and survival in patients with gliomas (2001) J Nucl Med, 42, pp. 1144-1150
Cook, G. J., Maisey, M. N., Fogelman, I., Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine (1999) Eur J Nucl Med, 26, pp. 1363-1378
EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(730 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote